Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10

Amir Behdad; Matthew John Schipma; Shuo Ma; Yi Hua Chen; Qing Ching Chen

doi:10.1080/10428194.2022.2123236

Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10

Amir Behdad^*, Matthew John Schipma, Shuo Ma, Yi Hua Chen, Qing Ching Chen

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	3222-3226
Number of pages	5
Journal	Leukemia and Lymphoma
Volume	63
Issue number	13
DOIs	https://doi.org/10.1080/10428194.2022.2123236
State	Published - 2022

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2022.2123236

Cite this

@article{b48f847a1d7b4140a6d4ab4fed63b911,

title = "Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10",

author = "Amir Behdad and Schipma, {Matthew John} and Shuo Ma and Chen, {Yi Hua} and Chen, {Qing Ching}",

note = "Funding Information: The authors acknowledge all the patients that were included in the study. The authors are thankful to David Dittmann for his help with next-generation sequencing.",

year = "2022",

doi = "10.1080/10428194.2022.2123236",

language = "English (US)",

volume = "63",

pages = "3222--3226",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "13",

}

TY - JOUR

T1 - Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10

AU - Behdad, Amir

AU - Schipma, Matthew John

AU - Ma, Shuo

AU - Chen, Yi Hua

AU - Chen, Qing Ching

N1 - Funding Information: The authors acknowledge all the patients that were included in the study. The authors are thankful to David Dittmann for his help with next-generation sequencing.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85138413880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138413880&partnerID=8YFLogxK

U2 - 10.1080/10428194.2022.2123236

DO - 10.1080/10428194.2022.2123236

M3 - Letter

C2 - 36102789

AN - SCOPUS:85138413880

SN - 1042-8194

VL - 63

SP - 3222

EP - 3226

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 13

ER -

Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this